L
Life Science REIT PLC
LSE:LABS
Life Science REIT PLC
LSE:LABS
Price:
38.8
GBX
0.52%
Market Closed
Market Cap:
£135.8m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
L
|
Life Science REIT PLC
LSE:LABS
|
UK |
|
Evercore Inc
NYSE:EVR
|
US |
|
Banca Popolare Di Sondrio SpA
MIL:BPSO
|
IT |
|
M
|
Man Industries India Ltd
NSE:MANINDS
|
IN |
|
G
|
Gevelot SA
PAR:ALGEV
|
FR |
|
Maisons du Monde SA
OTC:MDOUF
|
FR |
|
Ribo Fashion Group Co Ltd
SSE:603196
|
CN |
|
IFCI Ltd
NSE:IFCI
|
IN |
|
CSI Properties Ltd
HKEX:497
|
HK |
Income Statement
Earnings Waterfall
Life Science REIT PLC
Life Science REIT PLC
Income Statement
Life Science REIT PLC
Life Science REIT PLC
Currency: GBP
| Dec-2023 | Jun-2024 | Dec-2024 | Jun-2025 | ||
|---|---|---|---|---|---|
| Revenue | |||||
| Interest Expense |
5
|
6
|
7
|
0
|
|
| Revenue |
20
N/A
|
20
+1%
|
20
+1%
|
21
+4%
|
|
| Gross Profit | |||||
| Cost of Revenue |
(6)
|
(6)
|
(6)
|
(6)
|
|
| Gross Profit |
14
N/A
|
15
+5%
|
14
-1%
|
15
+5%
|
|
| Operating Income | |||||
| Operating Expenses |
(5)
|
(5)
|
(5)
|
(5)
|
|
| Selling, General & Administrative |
(5)
|
(5)
|
(5)
|
(5)
|
|
| Operating Income |
9
N/A
|
9
+10%
|
10
+2%
|
10
+9%
|
|
| Pre-Tax Income | |||||
| Interest Income Expense |
(28)
|
(48)
|
(23)
|
(41)
|
|
| Total Other Income |
(2)
|
(2)
|
(1)
|
0
|
|
| Pre-Tax Income |
(22)
N/A
|
(40)
-84%
|
(14)
+65%
|
(31)
-119%
|
|
| Net Income | |||||
| Tax Provision |
0
|
0
|
0
|
0
|
|
| Income from Continuing Operations |
(22)
|
(40)
|
(14)
|
(31)
|
|
| Net Income (Common) |
(22)
N/A
|
(40)
-84%
|
(14)
+65%
|
(31)
-119%
|
|
| EPS (Diluted) |
-0.06
N/A
|
-0.11
-83%
|
-0.04
+64%
|
-0.09
-125%
|
|
Switch to:
Switch to:
See Also
Discover More
